TRP Natural Eyes Floaters Relief Recalled for Lack of Sterility Assurance
TRP Natural Eyes Floaters Relief sterile eye drops are being recalled because the manufacturer cannot assure the product meets sterility standards. It was distributed to two direct accounts in Rhode Island and Colorado.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The product is a risk-of-harm product (sterile eye drops where contamination poses infection risk) with no reported illnesses, meeting the rubric criterion for Score 3. The Class II FDA classification confirms this is a meaningful safety risk warranting High severity.
Plain-English summary
TRP Natural Eyes, Floaters Relief sterile eye drops (10 mL, NDC: 17312-098-15) manufactured by AMMAN PHARMACEUTICAL INDUSTRIES in Jordan are being recalled. The FDA-initiated recall is due to lack of assurance of sterility.
Sterile eye drops must be free from microorganisms to be safe for application to the eye. A lack of assurance of sterility means the product does not meet the required safety standards and could pose a risk of bacterial infection or other complications if microbial contamination is present.
The recalled product was distributed to two direct accounts in Rhode Island and Colorado. The affected lots are DA001 (expiration 06/24) and DA002 (expiration 11/24), representing 18,171 units.
Consumers who have this product should stop using it and dispose of it safely. Anyone who has used the product and experiences eye discomfort, irritation, redness, or signs of infection should contact a healthcare provider.
The recalled product
- Product
- TRP Natural Eyes, Floaters Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-098-15.
- Manufacturer
- AMMAN PHARMACEUTICAL INDUSTRIES
- Category
- Drug — Eye Drops
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: DA001 EXP: 06/24
- Lot: DA002 EXP: 11/24
Distribution
Distributed in 2 states:
- CO
- RI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27